Acetylcholine-esterase inhibitor pyridostigmine decreases T cell overactivation in patients infected by HIV

AIDS Research and Human Retroviruses

Volumn 25, Issue 8, 2009, Pages 749-755

  Valdés Ferrer, Sergio Iván ^a,b   Crispín, José C ^a   Belaunzarán, Pablo Francisco ^a   Cantú Brito, Carlos G ^a   Sierra Madero, Juan ^a   Alcocer Varela, Jorge ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD69 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; IONOMYCIN; PLACEBO; PYRIDOSTIGMINE;

ABDOMINAL PAIN; ADULT; AGED; ANUS CONTINENCE; ARTICLE; CELL ISOLATION; CELL PROLIFERATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG TOLERANCE; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; REGULATORY T LYMPHOCYTE; SIDE EFFECT; T LYMPHOCYTE ACTIVATION;

ADULT; CELL PROLIFERATION; CHOLINESTERASE INHIBITORS; DOUBLE-BLIND METHOD; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-10; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; PYRIDOSTIGMINE BROMIDE; T-LYMPHOCYTES;

EID: 70349193231     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2008.0257     Document Type: Article

References (19)

1. Tracey KJ: The infiammatory refiex. Nature 2002;420:853-859.
2. Bernik TR, Friedman SG, Ochani M, et al.: Cholinergic antiinfiammatory pathway inhibition of tumor necrosis factor during ischemia reperfusion. J Vasc Surg 2002;36:1237-11236
3. Huston JM, Ochani M, Rosas-Ballina M, et al.: Splenectomy inactivates the cholinergic antiinfiammatory pathway dur ing lethal endotoxemia and polymicrobial sepsis. J Exp Med 2006;203:1623-1628.
4. Bernik TR, Friedman SG, Ochandi M, et al.: Systemic anti-infiammatory action of CNI-1493 mediated by the cholinergic anti-infiammatory pathway. J Exp Med 2002;195: 781-788.
5. Wang H, Yu M, Ochiani M, et al.: Nicotinic acetylcholine receptor a7 subunit is an essential regulator of inflammation. Nature 2003;421:384-388.
6. Czura CJ and Tracey KJ: Autonomic neural regulation of immunity. J Intern Med 2005;257:156-166.
7. Brenchley JM, Price DA, Schacker TW, et al.: Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 2006;12:1365-1371.
8. Malaspina A, Moir S, Kottilil S, et al.: Deleterious effect of HIV-1 plasma viremia on B cell costimulatory function. J Immunol 2003;170:5965-5972.
9. Hazenberg MD, Cohen Stuart JW, Otto SA, et al.: T-cell division in human immunodeficiency virus (HIV)-1 infection is mainly due to immune activation: A longitudinal analysis in patients before and during highly active antiretroviral therapy (HAART). Blood 2000;95:249-255.
10. Valdez H and Lederman MM: Cytokines and cytokine therapies in HIV infection. AIDS Clin Rev 1997;187-228.
11. Connolly NC, Riddler SA, and Rinaldo CR: Proinfiammatory cytokines in HIV disease--a review and rationale for new therapeutic approaches. AIDS Rev 2005;7:168-180
12. Brenchley JM, Price DA, and Douek DC: HIV disease: Fallout from a mucosal catastrophe? Nat Immunol 2006;7(3): 235-239.
13. Deeks S, Kitchen C, Liu L, et al.: Immune activation set point during early HIV infection predicts subsequent CD4T-cell changes independent of viral load. Blood 2004;104:942-947.
14. Keeler JR, Hurst CG, and Dunn MA: Pyridostigmine used as a nerve agent pretreatment under wartime conditions. JAMA 1991;266:693-695.
15. Crispfín JC, Martfínez A, de Pablo P, et al.: (1998) Participation of the CD69 antigen in the T-cell activation process of patients with systemic lupus erythematosus. Scand J Immunol 1998;48:196-200.
16. Tsunemi S, Iwasaki T, Imado T, et al.: Relationship of CD4PCD25 regulatory T cells to immune status in HIV-infected patients. AIDS 2005;19:879-886.
17. Weiss L, Donkova-Petrini V, Caccavelli L, et al.: Human immunodeficiency virus-driven expansion of CD4PCD25Pregulatory T cells which suppress HIV-specific CD4-T cell response in HIV-infected patients. Blood 2004;104:3249-3256.
18. Kinter AL, Henessey M, Bell A, et al.: CD25PCD4Pregulatory T cells from the peripheral blood of asymptomatic HIV-infected individuals regulate CD4Pand CD8PHIVspecific T cell immune responses in vitro and are associated with favorable clinical markers of disease status. J Exp Med 2004;200:331-343.
19. Kawashima K and Fujii T: Expression of non-neural acetylcholine in lymphocytes and its contribution to the regulation of immune function. Front Biosci 2004;9:2063-2085.